Sera Prognostics Presents Data from Second Study on Preterm Birth Protein Biomarkers
February 18, 2011
Sera Prognostics Presents Data from Second Study on Preterm Birth Protein Biomarkers
According to a preliminary analysis of the results, the panel is able to predict preterm birth at 24 and 28 weeks gestation with 92 percent sensitivity and 86 percent specificity.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sera Prognostics Raises $1.4M to Fund Development of Protein Biomarker Test for Preterm Births
January 7, 2011 / ProteoMonitor - Sera Prognostics' 4,000-Patient Validation Study Another Sign of High-Throughput Mass Spec's Arrival
March 1, 2013 / ProteoMonitor - Agilent, Sera Prognostics Team on Proteomic Assays
February 12, 2013 / GenomeWeb Daily News - People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor